MCKESSON CORP

MCK · XNYS

CIK 927653fmd_14M0XKGNY8HHJ6D503CFRMPFK8Wholesale Trade · Wholesale-Drugs, Proprietaries & Druggists' SundriesTemplate: Standard

Coverage: Apr 01, 2007 to Sep 30, 2026, 75 periods

Income Statement · Annual · Millions · USD
Line item	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026
Total revenues	198,533	208,357	214,319	231,051	238,228	263,966	276,711	308,951	359,051	403,430
Cost of revenue	187,262	197,173	202,565	219,028	226,080	250,836	264,353	296,123	345,728	388,880
Gross profit	11,271	11,184	11,754	12,023	12,148	13,130	12,358	12,828	13,323	14,550
Research and development	341	125	71	96	–	–	–	–	–	–
Selling, general and administrative	7,447	8,138	8,437	9,182	8,849	10,537	7,776	8,657	8,507	8,096
Total operating expenses	4,149	10,422	10,868	9,534	17,188	11,092	7,977	8,919	8,901	8,338
Operating income	7,122	762	886	2,489	(5,040)	2,038	4,381	3,909	4,422	6,212
Interest expense	308	283	264	249	217	178	248	252	265	247
Interest and investment income	29	48	39	49	12	10	107	118	173	179
Other non-operating income (expense)	77	130	182	12	223	259	497	132	202	236
Income before taxes	6,891	239	610	1,144	(5,034)	1,928	4,630	3,789	4,359	6,201
Income tax expense	1,614	(53)	356	18	(695)	636	905	629	878	1,102
Net income from continuing operations	5,277	292	254	1,126	(4,339)	1,292	3,725	3,160	3,481	5,099
Net income	5,070	67	34	900	(4,539)	1,114	3,560	3,002	3,295	4,762
Net income to common shareholders	–	–	–	–	–	–	–	–	–	–